Search details
1.
Alpha-kinase 1 (ALPK1) agonist DF-006 demonstrates potent efficacy in mouse and primary human hepatocyte (PHH) models of hepatitis B.
Hepatology
; 77(1): 275-289, 2023 01 01.
Article
in English
| MEDLINE | ID: mdl-35699669
2.
Identification of apilimod as a first-in-class PIKfyve kinase inhibitor for treatment of B-cell non-Hodgkin lymphoma.
Blood
; 129(13): 1768-1778, 2017 03 30.
Article
in English
| MEDLINE | ID: mdl-28104689
3.
Phase II activity of belinostat (PXD-101), carboplatin, and paclitaxel in women with previously treated ovarian cancer.
Int J Gynecol Cancer
; 22(6): 979-86, 2012 Jul.
Article
in English
| MEDLINE | ID: mdl-22694911
4.
Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors.
Biochem J
; 409(2): 581-9, 2008 Jan 15.
Article
in English
| MEDLINE | ID: mdl-17868033
5.
LAM-003, a new drug for treatment of tyrosine kinase inhibitor-resistant FLT3-ITD-positive AML.
Blood Adv
; 3(22): 3661-3673, 2019 11 26.
Article
in English
| MEDLINE | ID: mdl-31751472
6.
Differential effects of class I isoform histone deacetylase depletion and enzymatic inhibition by belinostat or valproic acid in HeLa cells.
Mol Cancer
; 7: 70, 2008 Sep 12.
Article
in English
| MEDLINE | ID: mdl-18789133
7.
Activity of the histone deacetylase inhibitor belinostat (PXD101) in preclinical models of prostate cancer.
Int J Cancer
; 122(6): 1400-10, 2008 Mar 15.
Article
in English
| MEDLINE | ID: mdl-18027850
8.
Plasma and cerebrospinal fluid pharmacokinetics of the histone deacetylase inhibitor, belinostat (PXD101), in non-human primates.
Cancer Chemother Pharmacol
; 62(3): 433-7, 2008 Aug.
Article
in English
| MEDLINE | ID: mdl-17960383
9.
Treatment parameters modulating regression of human melanoma xenografts by an antibody-drug conjugate (CR011-vcMMAE) targeting GPNMB.
Cancer Chemother Pharmacol
; 60(3): 423-35, 2007 Aug.
Article
in English
| MEDLINE | ID: mdl-17541593
10.
CR011, a fully human monoclonal antibody-auristatin E conjugate, for the treatment of melanoma.
Clin Cancer Res
; 12(4): 1373-82, 2006 Feb 15.
Article
in English
| MEDLINE | ID: mdl-16489096
11.
Activity of PXD101, a histone deacetylase inhibitor, in preclinical ovarian cancer studies.
Mol Cancer Ther
; 5(8): 2086-95, 2006 Aug.
Article
in English
| MEDLINE | ID: mdl-16928830
12.
B-cell non-Hodgkin lymphoma: Selective vulnerability to PIKFYVE inhibition.
Autophagy
; 13(6): 1082-1083, 2017 Jun 03.
Article
in English
| MEDLINE | ID: mdl-28350209
13.
Platelet-derived growth factor D: tumorigenicity in mice and dysregulated expression in human cancer.
Cancer Res
; 62(9): 2468-73, 2002 May 01.
Article
in English
| MEDLINE | ID: mdl-11980634
14.
Angioarrestin: an antiangiogenic protein with tumor-inhibiting properties.
Cancer Res
; 62(13): 3834-41, 2002 Jul 01.
Article
in English
| MEDLINE | ID: mdl-12097297
15.
Recombinant semaphorin 6A-1 ectodomain inhibits in vivo growth factor and tumor cell line-induced angiogenesis.
Cancer Biol Ther
; 4(6): 659-68, 2005 Jun.
Article
in English
| MEDLINE | ID: mdl-15917651
16.
Preclinical characterization of CG53135 (FGF-20) in radiation and concomitant chemotherapy/radiation-induced oral mucositis.
Clin Cancer Res
; 9(9): 3454-61, 2003 Aug 15.
Article
in English
| MEDLINE | ID: mdl-12960137
17.
Angioarrestin: a unique angiopoietin-related protein with anti-angiogenic properties.
Biochem Biophys Res Commun
; 333(2): 308-15, 2005 Jul 29.
Article
in English
| MEDLINE | ID: mdl-15950186
18.
Fibroblast growth factors in cancer: therapeutic possibilities.
Expert Opin Ther Targets
; 6(4): 469-82, 2002 Aug.
Article
in English
| MEDLINE | ID: mdl-12223061
19.
A novel human fibroblast growth factor treats experimental intestinal inflammation.
Gastroenterology
; 123(4): 1151-62, 2002 Oct.
Article
in English
| MEDLINE | ID: mdl-12360478
20.
A fully human monoclonal antibody (CR002) identifies PDGF-D as a novel mediator of mesangioproliferative glomerulonephritis.
J Am Soc Nephrol
; 14(9): 2237-47, 2003 Sep.
Article
in English
| MEDLINE | ID: mdl-12937299
Results
1 -
20
de 20
1
Next >
>>